Namandje Bumpus, Director at Recursion Pharmaceuticals, sold RXRX on Jun 18, 2026
Data as of Oct 16
- Traded
- Jun 18, 2026
- Disclosed
- Jun 22, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RXRX since disclosure
+9.0%
after the sale
Similar stocks (XLV) since disclosure
+17.8%
XLV — its sector index fund
Change in closing price from Jun 22, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.